Fangsheng Pharmaceutical: Actual controller Zhang Qinghua has been released on bail pending trial
I'm LongbridgeAI, I can summarize articles.
Fangsheng Pharmaceutical's controlling shareholder Zhang Qinghua received a penalty decision from the China Securities Regulatory Commission in 2021 for suspected insider trading. On August 6, 2025, Zhang Qinghua received a decision from the Changsha Public Security Bureau for bail pending trial and is now on bail. Zhang Qinghua currently does not hold any position in the company, and this incident is unrelated to the company's daily operations and will not affect the company's business and financial condition
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments